A survey of paediatric anaesthetists in 2002 reported that more than 50% of anaesthetists used an adjuvant drug when performing caudal analgesia with the most commonly used being ketamine, clonidine, fentanyl, and diamorphine. 1 Ketamine has been shown to have a synergistic effect with caudal local anaesthetics. 2 Ketamine local anaesthetics combinations have been demonstrated to speed the onset of analgesia, prolong the duration of caudal analgesia, and reduce the incidence of ineffective analgesia. 3 -5 Epidural ketamine has allowed lower concentrations of bupivacaine and ropivacaine to be used and as a result, the incidence of postoperative motor block has been lower. 3 S(þ)-ketamine 0.5 mg kg 21 added to 0.20 -0.25% of bupivacaine or ropivacaine for caudal anaesthesia is highly effective in improving the quality and duration of the analgesia in children. 4 5 Levobupivacaine has been demonstrated to be an extremely effective agent for caudal analgesia, 6 -8 but its use in combination with ketamine has not previously been reported. We conducted this doubleblind randomized controlled trial to determine if ketamine added to lower concentrations of levobupivacaine is as effective as levobupivacaine 0.2% alone for caudal anaesthesia in children.
Methods
After approval from the Hospital Research Ethics Committee, informed written consent was obtained from the parents of 180 children. Patients undergoing elective lower abdominal or urological procedures of anticipated duration ,120 min who were between 3 months and 6 yr of age, with ASA score I -III, and weighing ,20 kg were enrolled.
Anaesthetic technique
All children were fasted and received oral or rectal premedication with midazolam 0.5 mg kg 21 30-45 min before surgery. I.V. anaesthesia was induced with propofol 2 -4 mg kg 21 and maintained by sevoflurane at ,1 MAC (age adjusted) in 50% oxygen -air mixture administered by laryngeal mask airway or endotracheal tube without neuromuscular blocking agents. Ventilation was not controlled until after the first skin incision and assessment of ventilatory response to the stimuli had been made. Ventilation was then controlled or assisted in order to obtain an endtidal carbon dioxide (E 0 CO 2 ) 45 mm Hg. After induction of anaesthesia, patients were placed in the lateral decubitus position and a consultant anaesthetist performed a caudal block using a 22 G i.v. cannula. The children were randomized in double-blind fashion into three separate groups. The first group received 1 ml kg 21 of levobupivacaine 0.15% (Chirocaina ) without ketamine. The randomization sequence was computer generated and the drugs were prepared in a double-blinded manner.
Non-invasive blood pressure (BP), heart rate (HR), respiratory rate (RR), oxygen saturation, and end-tidal CO 2 were monitored continuously. Three minutes after local anaesthetic injection, a mechanical stimulus was applied at the surgical dermatome or at the immediate superior dermatome with a modified Allis clamp (m 30-132 -15, Martin w ; Tuttlingen, Germany) for the evaluation of block onset. 9 Patients were stimulated every 3 min after the caudal block until block effectiveness or a maximum of 15 min after caudal injection (five stimuli). Any related movement or significant change in the HR or RR resulted in the discontinuation of the stimulus. Analgesic onset time was defined as the time in minutes between local anaesthetic injection and the absence of gross movement or significant (.20%) change in HR, BP, or RR on application of the clamp. A physiological response or movement at 15 min was considered as prolonged local anaesthetic onset. Data from patients who responded with movements or physiological changes to the fifth stimulus but did not respond to first surgical stimulus were assigned an onset time equivalent to the time between caudal block and surgical incision.
Caudal block efficacy during surgery was defined as the absence of gross movements or significant (.20%) change in BP, HR, or RR associated with surgical stimulation. In the event of gross movements or significant physiological changes after incision or during surgery, children were treated with an i.v. bolus of fentanyl 2 mg kg
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. The primary endpoint of the study was the quality of postoperative pain control. This was defined by the number of children requiring rescue analgesia because of a Children and Infants Postoperative Pain Scale (CHIPPS) Scale 4 during the first 6 h after caudal block. Postoperative pain was evaluated using the CHIPPS 10 ( . In the postoperative recovery ward, pain intensity, emergence agitation, and Aldrete scores were recorded every 10 min until an Aldrete score of 8 was achieved. 11 The postoperative behaviour of the children was evaluated using a fourpoint scale. These were: (1) calm child: does not need any kind of intervention; (2) consolable child: requires only physical contact with the parents; (3) agitated child: a screaming and crying child; and (4) aggressive child: must be physically restrained in order to avoid harming himself. We defined postoperative agitation as a score of three or four points. 12 We did not perform structured neurobehavioural testing and documentation of odd behaviour on awakening was recorded on an observational basis.
The incidence of residual motor blockade was considered a secondary outcome measure and was evaluated using a modified Bromage scale. A score of 0 was assigned if no motor block was present. A score of 1 indicated an inability to stand unassisted, 2 indicated ability to flex the ankle but not the knee, and 3 indicated complete motor block in a fully awake child. Significant residual motor blockade was defined as a motor block score equal to or greater than 1 point after awakening and 180 min after the last dose of local anaesthetic. In the event of an asymmetric block, the highest numerical value was recorded. An anaesthetist not primarily responsible for the conduct of the anaesthetic carried out preoperative evaluation and data collection. This anaesthetist obtained informed consent, confirmed validity of the inclusion criteria, and allocated the patients using computer-generated random number sequence to the study groups. In the event of an emergency related or possibly related to the study or study drugs, the pharmacist was authorized to disclose the contents of the syringe to the consultant anaesthetist. The study blinding was broken before statistical analysis.
Statistical analysis
The initial sample size estimation was performed based on a number of assumptions from prior studies of caudal anaesthesia in children. Assuming an incidence pain after surgery of 0.5, a two-sided type I error of 0.05, a power of 0.80, and an effect size of 0.50, more than 55 in each group were required to find a significant difference in the number of children requiring rescue analgesia in the first hours after surgery.
Quantitative data are presented as mean, standard deviation or range, and qualitative data as frequency and 95% confidence interval (95% CI). ANOVA or Kruskal-Wallis test was used for analysis of differences in age, weight, analgesic onset time, surgical time; wakeup time, and postoperative analgesic time. Type of surgery, ASA physical status, sex, block effectiveness during operation, residual motor blockade, postoperative agitation, and number of patients requiring analgesics after operation were analysed with x 2 or Fisher's exact test. Pain and sedation scores (at various times) and frequency of rescue analgesia were compared using Mann -Whitney U-tests. The incidence and time to first rescue analgesia were analysed using Kaplan-Meier survival analysis with comparison between the groups using the log-rank test. Survival data were defined as time from caudal anaesthesia to the requirement of first rescue analgesia. Patients who did not require rescue analgesia during the 6 h of observation were considered 'censored'. The Mantel-Cox (log-rank) test was used to perform intergroup comparisons.
Results
One hundred and eighty children were included in the study, 164 were analysed as per protocol and 16 children were excluded. Fourteen patients did not receive the drug under study (seven in Group 2, four in Group 1, and three in Group 3). One child in Group 3 underwent local and peripheral block because of technical difficulties with the epidural block. One patient in Group 2 was lost to follow-up.
The clinical characteristics of the children are shown in Table 2 . There were no significant differences in age, weight, gender, type of surgery, surgery time, end-tidal sevoflurane concentration during surgery, time to awakening, or postoperative agitation.
Analgesic onset time measured with a mechanical stimulus was not significantly different between the three groups. Median analgesic onset was 6 (IQR 6 -9) min in Groups 1 and 2, and 9 (IQR 6-9) min in Group 3. Analgesic onset exceeding 15 min (manifesting as movements or physiological changes to the fifth mechanical stimulus) was present in seven children in Group 2 compared with two children in each of the other groups (x 2 P¼0.06). There were no significant haemodynamic changes after caudal boluses and during surgery for any agent.
There were no significant differences between the groups in the proportion of children with effective epidural block at the first surgical incision (x 2 P¼0.13). Adequate analgesia on first incision was demonstrated in 56 patients (95% CI 85-99%) in Groups 1 and 3 and 50 children (95% CI 87-99%) in Group 2. Two children (95% CI 0 -13) in Group 2 received an extra dose of i.v. fentanyl after incision (x 2 P¼0.73). CHIPPS scores at wakeup were significantly different between Group 2 and Group 3 at wakeup (Wilcoxon rank sum P¼0.05) but at no other time up to 360 min (Fig. 1 ). There were no significant differences between Group 1 and Group 3 (P¼0.38) or Group 1 and Group 2 (P¼0.44) at any time. The contribution of sedation induced by systemic absorption of caudal ketamine to lower CHIPPS 
Discussion
The key finding of this study is that the addition of 0.5 mg kg 21 of preservative-free S(þ)-ketamine to caudal levobupivacaine 0.175% significantly decreases the need for rescue analgesia in the immediate postoperative period. When S(þ)-ketamine 0.5 mg kg 21 is added to 0.15% caudal levobupivacaine, the quality of postoperative analgesia is equivalent to that produced with caudal 0.2% levobupivacaine alone. This is consistent with previous reports of caudal ketamine in association with bupivacaine and ropivacaine for intra-and postoperative analgesia. 13 14 Ketamine local anaesthetics combinations have been shown to speed the onset of analgesia, prolong the duration of caudal analgesia, and reduce the incidence of ineffective analgesia compared with local anaesthetics alone. 4 5 Most studies use the duration of postoperative analgesia or the time to first analgesic request to determine the effect of ketamine on local anaesthetic effectiveness. When racemic ketamine 0.25 mg kg 21 is added to bupivacaine or ropivacaine for caudal anaesthesia, the duration of postoperative Fig 2 Results of Kaplan-Meier survival analysis are displayed as survival curves for the three caudal solutions. Mantel-Cox (log-rank) test was used to compare the rate of requirement for additional analgesia in the study with the rate of expected requirements for additional analgesia if all groups had received equally effective caudal analgesia. Group 1 (0.15% levobupivacaine with 0.5 mg kg 21 ketamine) was significantly different (P¼0.05) to Group 2 (0.175% levobupivacaine with 0.5 mg kg 21 ketamine) but not Group 3 (0.2% levobupivacaine) (P¼0.27). There was no significant difference between Group 2 and Group 3 (P¼0.15). analgesia is 8 -12 h. Increasing the dose to racemic ketamine 0.5 mg kg 21 does not substantially increase the duration of analgesia or reduce the proportion of patients requiring postoperative analgesia. Using S(þ)-ketamine 0.5 mg kg 21 with bupivacaine or ropivacaine appears to not confer any advantages over the racemic local anaesthetic mixtures, despite a four-fold increase in potency. Because our patients were observed for only 6 h after surgery, no firm conclusions on the exact duration of action of caudally administered S(þ)-ketamine can be made and no direct comparison with ropivacaine or bupivacaine solutions is possible. Despite this restriction, 57% of patients in the 0.175% of levobupivacaine ketamine group did not require analgesia up to 6 h after operation. This is consistent with other studies reporting the proportion of patients requiring postoperative analgesia. The optimum dose of ketamine to add a local anaesthetic or other analgesic for neuraxial anaesthesia to improve or prolong postoperative analgesia, however, has not been determined. As there is an unacceptable incidence of behavioural side-effects with 1 mg kg 21 , our study used 0.5 mg kg 21 . 15 When racemic ketamine 0.25 mg kg 21 is combined with bupivacaine 0.25% only 7% of the ketamine/bupivacaine group required any analgesia in the 24 h post-surgery compared with 20% of ketamine only caudals and 50% of bupivacaine only caudals. 16 The addition of ketamine 0.5 mg kg 21 to bupivacaine 0.25% produces a longer median duration of analgesia after orchidopexy than either clonidine 2 mg ml 21 or adrenaline 5 mg ml
21
. 17 Similarly, racemic ketamine 0.25 mg kg 21 with caudal ropivacaine 0.2% increases the median duration of analgesia from 3 to 12 h. 18 The anaesthetic potency of S(þ)-ketamine is twice that of the racemic mixture due to a three-fold greater affinity for the N-methyl-D-aspartate (NMDA) receptor. This difference in affinity for the NMDA receptor does not appear to translate into differences in clinical effectiveness. The difference in affinity does not translate into a halving of the dose required to provide analgesia. Studies where racemic ketamine 0.25 mg ml 21 is added to solutions of bupivacaine or ropivacaine for caudal anaesthesia produce the same duration of analgesia as studies using S(þ)-ketamine 0.5 mg ml
, despite a four-fold potency difference. One conclusion is that there is a ceiling effect on the concentration of ketamine and another is that the concentration of local anaesthetic is much more critical to the effect than the ketamine dose. Other advantages of S(þ)-ketamine include fewer psychomotor side-effects, less salivation, and shorter recovery time compared with the racemic mixture. A number of studies have examined the effect of a combination of caudal S(þ)-ketamine and local anaesthetics on perioperative analgesia. 19 -21 Marhofer and colleagues 19 reported that caudal S(þ)-ketamine 1 mg kg 21 provided equipotent intra-and postoperative analgesia compared with 0.75 ml kg 21 of bupivacaine 0.25% with 1:200 000 adrenaline but 0.5 mg kg 21 provided sufficient analgesia only during the intraoperative period. De Negri and colleagues 5 found that the addition of S(þ)-ketamine 0.5 mg kg 21 to ropivacaine 0.2% for lower abdominal surgery resulted in an improvement in postoperative analgesia compared with ropivacaine alone.
Using neuraxial analgesics other than local anaesthetics may confer distinct advantages such as avoiding motor blockade and the serious complications associated with inadvertent intravascular injection of the local anaesthetic solution. Inadvertent intravascular injection of ketamine will not result in significant complications, as the caudal dose is lower than the i.v. dose. Ketamine, however, has a relatively short duration of action when used alone. A combination of caudal ketamine and clonidine 22 23 or tramadol is effective but associated with unacceptable sedation or significant PONV. 24 25 In our study, caudal ketamine 0.5 mg kg 21 did not increase the incidence of emergence agitation, PONV, or residual motor blockade. Side-effects of ketamine such as delirium, hallucinations, or nightmares can occur with caudal ketamine at doses of 0.5-1 mg kg 21 16 but have not been reported at doses of 0.25 mg kg 21 . 18 26 Toxic reactions after prolonged neuraxial exposure to racemic ketamine formulations with preservatives (benzethonium chloride or chlorbutanol) have been reported in animal species. 27 28 Spinal neurotoxicity after continuous intrathecal racemic ketamine infused over 3 weeks for terminal cancer-related pain has been reported. 29 Controversy exists about the risk-benefit ratio of neuraxial ketamine. As a result, only preservative-free S(þ)-ketamine should be used for neuraxial anaesthesia. The risk of spinal toxicity, however, is greatest in prolonged subdural administration for cancer pain. Physiological NMDA receptor activity is necessary for cell survival and cerebral function and prolonged NMDA receptor blockade by ketamine results in apoptosis of central neurons of immature rat brain. 30 As yet, no permanent neurological injury has resulted from singleshot caudal ketamine use but caution is warranted.
In conclusion, the addition of 0.5 mg kg 21 of S(þ)-ketamine to caudal levobupivacaine 0.175% significantly decreases the need for rescue analgesia in children undergoing abdominal and urological surgery compared with levobupivacaine 0.2%. The effect of ketamine added to levobupivacaine 0.15% is as effective as levobupivacaine 0.2% alone. Preservative-free S(þ)-ketamine may be used by the caudal route as a local anaesthetic sparing agent allowing lower concentrations of levobupivacaine to be used. To determine if the effect of ketamine is synergistic or purely additive would require isobolographic analysis.
